You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DESOGEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Desogen, and when can generic versions of Desogen launch?

Desogen is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in DESOGEN is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESOGEN?
  • What are the global sales for DESOGEN?
  • What is Average Wholesale Price for DESOGEN?
Summary for DESOGEN
Drug patent expirations by year for DESOGEN
Recent Clinical Trials for DESOGEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Oregon Health and Science UniversityN/A
Oregon Clinical and Translational Research InstituteN/A

See all DESOGEN clinical trials

US Patents and Regulatory Information for DESOGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-21 020071-001 Dec 10, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-28 020071-002 Dec 10, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DESOGEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-21 020071-001 Dec 10, 1992 ⤷  Sign Up ⤷  Sign Up
Organon Usa Inc DESOGEN desogestrel; ethinyl estradiol TABLET;ORAL-28 020071-002 Dec 10, 1992 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.